non-small cell lung cancer
Conditions
Interventions
Gemcitabine / Docetaxel
Sponsors
Nagano Prefecture lung cancer chemotherapy Study Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.The example of treating Mi in the non-small cell lung cancer and patients who obtained the conviction according to the cytology the organization and looking after cannot excision patient who has untreated disease and recurrent disease 2.Case of PS 0-2 3.Patient of Omoats abnormality of hepatic function and kidney function who not is (a)Cr50ml/min (b)T.Bil<2.0mg/dl,GOT,GPT<2xupper normal limit 4.The number of 4000 of the leukocyte count or more before it treats and the number of 2000 of neutrophil count or more, and the number of platelets is 100000 or more, and Hb 10.0/dl or more. 5.Case who obtained agreement by document 6.Have the change to a morbid state that can be measured or can evaluated for the survival time of three months More to be expected more than administering beginning day.
Exclusion criteria
Exclusion criteria: 1.It a large amount is pericardial fluid with the subjective symptom is does pleural effusion or is a patient who admits as for the peritoneal fluid. 2.Patient with bone metastasis and brain metastasis focus where vena cava superior syndrome and pain are strong to need radiotherapy in emergency 3.It is a patient from whom the having infectious disease is doubted as for the patient and generation of heat that has the infectious disease. 4.It is a patient who has as for the syndrome of complication. 5.Patient who has clear tip neurological symptom (However, the one that originates in an original disease is excluded). 6.Patient who has the past of clear medicine hypersensitivity to treatment 7.Case from whom interstitial pneumonia or fibroid lung clear because of simple X rays of chest is admitted 8.Patient who has pregnant woman or possibility of pregnancy Case who judged that physician in charge is improper to this treatment object
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety | — |
Countries
Japan
Contacts
Public Contactyosida kazuo
Shinshu University School of Medicine Department of Respiratory organ surgery
Outcome results
None listed